Beneficial Effects of Tumor Necrosis Factor-alpha Inhibition by Pentoxifylline on Clinical, Biochemical, and Metabolic Parameters of Patients with Nonalcoholic Steatohepatitis-Reference-Cited by-同舟云学术

Beneficial Effects of Tumor Necrosis Factor-alpha Inhibition by Pentoxifylline on Clinical, Biochemical, and Metabolic Parameters of Patients with Nonalcoholic Steatohepatitis

Published:2004-10 Issue:10 Volume:99 Page:1946-1952
ISSN:0002-9270
Container-title:The American Journal of Gastroenterology
language:en
Short-container-title:Am J Gastroenterology

Author:

Satapathy Sanjay K.,Garg Sanjay,Chauhan Ranjeet,Sakhuja Puja,Malhotra Veena,Sharma Barjesh C.,Sarin Shiv K.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference40 articles.

1. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆

2. Histological course of alcoholic hepatitis

3. Natural History of Alcoholic Hepatitis

4. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis

Cited by 173 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The “Domino effect” in MASLD: The inflammatory cascade of steatohepatitis;European Journal of Immunology;2024-02-05

2. Coumestrol as a new substance that may diminish lipid precursors of the inflammation in steatotic primary rat hepatocytes;Biochimie;2023-01

3. The biological clock enhancer nobiletin ameliorates steatosis in genetically obese mice by restoring aberrant hepatic circadian rhythm;American Journal of Physiology-Gastrointestinal and Liver Physiology;2022-10-01

4. A raising dawn of pentoxifylline in management of inflammatory disorders in Covid-19;Inflammopharmacology;2022-04-29

5. Fatigue in chronic liver disease patients: prevalence, pathophysiology, and management;Gastroenterology Review;2022